IceCure, a biomedical company that develops minimally invasive therapies for women’s health, announced that it successfully removed benign breast cancer tumors from patients in a clinical trial conducted in Kamogowa, Japan. The company’s IceSense3 Cryoablation system is an ultrasound-guided procedure that penetrates the tumor and then removes it with extreme cold, thus replacing the need for surgical excision of the tumors. IceCure is headquartered in Caesarea, Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments